Publicacións en colaboración con investigadores/as de Hospital de Cruces (15)

2024

  1. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer, Vol. 71, Núm. 8

  2. Re-irradiation for progressive Diffuse Intrinsic Pontine Glioma (DIPG): The Spanish experience

    EJC Paediatric Oncology, Vol. 4

2023

  1. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

2022

  1. Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network

    European Journal of Pediatrics, Vol. 181, Núm. 2, pp. 789-799

2019

  1. Topiramate plus cooling for hypoxic-ischemic encephalopathy: A randomized, controlled, multicenter, double-blinded trial

    Neonatology, Vol. 116, Núm. 1, pp. 76-84

2018

  1. Fabry disease in the Spanish population: Observational study with detection of 77 patients

    Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1

  2. Oxidative stress in perinatal asphyxia and hypoxic-ischaemic encephalopathy

    Anales de Pediatria, Vol. 88, Núm. 4, pp. 228.e1-228.e9

2017

  1. Evolution of energy related metabolites in plasma from newborns with hypoxic-ischemic encephalopathy during hypothermia treatment

    Scientific Reports, Vol. 7, Núm. 1

  2. Importancia de los enterovirus en neuropediatría: De los poliovirus a otros enterovirus

    Revista de Neurologia, Vol. 64, pp. S35-S38

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

2015

  1. Corrigendum to "Risk factors for developing mineral bone disease in phenylketonuric patients" [Mol. Genet. Metab. 108 (2013) 149-154]

    Molecular Genetics and Metabolism

2014

  1. Design and validation of a real-time RT-PCR for the simultaneous detection of enteroviruses and parechoviruses in clinical samples

    Journal of Virological Methods, Vol. 208, pp. 125-128

2013

  1. Risk factors for developing mineral bone disease in phenylketonuric patients

    Molecular Genetics and Metabolism, Vol. 108, Núm. 3, pp. 149-154

2005

  1. Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention

    Acta Paediatrica, International Journal of Paediatrics, Vol. 94, Núm. 4, pp. 451-457

2000

  1. Estudio prospectivo sobre el empleo de catéteres umbilicales en el recién nacido

    Anales Espanoles de Pediatria, Vol. 53, Núm. 5, pp. 470-478